SSR4
Translocon-associated protein subunit delta
Also known as: SSRD_HUMAN, TRAPD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51571
- Gene
- SSR4
- Ensembl
- ENSG00000180879
- Chromosome
- X
- Canonical length
- 173 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
This gene encodes the delta subunit of the translocon-associated protein complex which is involved in translocating proteins across the endoplasmic reticulum membrane. The encoded protein is located in the Xq28 region and is arranged in a compact head-to-head manner with the isocitrate dehydrogenase 3 (NAD+) gamma gene and both genes are driven by a CpG-embedded bidirectional promoter. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
173 residues, UniProt reviewed canonical sequence.
>P51571|SSR4
1 MAAMASLGAL ALLLLSSLSR CSAEACLEPQ ITPSYYTTSD AVISTETVFI VEISLTCKNR
61 VQNMALYADV GGKQFPVTRG QDVGRYQVSW SLDHKSAHAG TYEVRFFDEE SYSLLRKAQR
121 NNEDISIIPP LFTVSVDHRG TWNGPWVSTE VLAAAIGLVI YYLAFSAKSH IQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SSR4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 2,940 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 2,940 nTPM
- salivary gland: 868 nTPM
- epididymis: 836 nTPM
- pituitary gland: 693 nTPM
- choroid plexus: 504 nTPM
- bone marrow: 470 nTPM
Single-cell type
- plasma cells: 6,648 nCPM
- late spermatids: 2,867 nCPM
- epididymal principal cells: 2,739 nCPM
- gastric chief cells: 2,477 nCPM
- pancreatic acinar cells: 1,814 nCPM
- pancreatic islet cells: 1,447 nCPM
Immune cell
- plasmacytoid DC: 1,757 nTPM
- total PBMC: 1,332 nTPM
- MAIT T-cell: 764 nTPM
- NK-cell: 699 nTPM
- memory B-cell: 699 nTPM
- basophil: 654 nTPM
Brain region
- choroid plexus: 167 nTPM
- hypothalamus: 158 nTPM
- white matter: 116 nTPM
- spinal cord: 99 nTPM
- medulla oblongata: 97 nTPM
- thalamus: 91 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SSR4.
Disease | AllUniProt
Conditions SSR4 is implicated in, by any mechanism.
- Congenital disorder of glycosylation 1Y (CDG1Y) MIM:300934
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 178 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- SSR4-congenital disorder of glycosylation
- Nonpapillary renal cell carcinoma
- Thyroid cancer, nonmedullary, 1
- Inborn genetic diseases
- Ovarian serous cystadenocarcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Translocon-associated
- Translocon-associated protein, delta subunit precursor (TRAP-delta)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SSR4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SSR4 as an antibody target. Whether an autoantibody or antibody against SSR4 could matter depends on whether native SSR4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SSR4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SSR4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...